METHOD FOR TREATING CHRONIC GLOMERULONEPHRITIS

FIELD: medicine, nephrology. SUBSTANCE: one should subcutaneously inject low-molecular heparin - clevarin at the dose of 0.25 ml containing 1750 anti-Xa IU once daily for the course of 15-20 d. Said innovation enables to shorten the number of injections, excludes possibility for development of throm...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	TYCHININA S.A, TRUSOV V.V, KAZAKOVA I.A
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine, nephrology. SUBSTANCE: one should subcutaneously inject low-molecular heparin - clevarin at the dose of 0.25 ml containing 1750 anti-Xa IU once daily for the course of 15-20 d. Said innovation enables to shorten the number of injections, excludes possibility for development of thrombocytopenia and osteoporosis and prevents hemorrhagic complications. EFFECT: higher efficiency of therapy. 2 ex